Aberdeen-based biotech company wins Scotland’s Life Sciences Award
Dr Edward Green, CEO of Aberdeen-based biotech company NCIMB Ltd has won the Business Leadership Award at Scotland’s Life Sciences Awards. The evening, which was held in Glasgow on the 13th of March, was a fantastic celebration of all that the Scottish life sciences sector is achieving. Award categories included Business Leadership, Innovation, Innovative Collaboration, Outstanding Skills Development, Global Export Impact, Rising Stars, and Lifetime Achievement.
Edward joined NCIMB as Chief Executive in August 2022, bringing expertise in microbiology, industrial biotechnology, and bio-entrepreneurship. Tasked with revitalizing the business, he has focused on strengthening core services, unlocking the commercial potential of NCIMB’s microbial strain collection, and securing strategic partnerships. His leadership has driven innovation, refined licensing models, and fostered a culture of ambition, positioning NCIMB as a dynamic, high-growth player in industrial biotechnology.
Dr Edward Green, CEO of Aberdeen-based biotech company NCIMB Ltd
NCIMB is a well-established biotechnology company providing innovative microbial solutions for life sciences, food & drink, energy and environmental businesses. The company provides microbial sequencing, identification and storage services, and supplies strains from the UK’s largest and most diverse collection of bacteria for biotech applications.
Commenting on the win, Dr Green said: “I am delighted to have won this award but couldn’t have done it without the amazing team of microbiology experts that I lead. The team at NCIMB has demonstrated good leadership over four decades as they have flexed to accommodate the changes in the life sciences market and support customer’s needs. Today, biotechnology is at the forefront of tackling many of the grand societal challenges including decarbonisation, climate change and health, and this means that NCIMB’s microbial platform is more relevant today than it has ever been. I’m excited about the opportunities this creates for NCIMB and our long-term vision to deploy our unique microbial platform to deliver impactful solutions.”
